U.S. pharma giant copyright scrapped two experimental weight loss supplements final yr—a at the time-day-to-day tablet, lotiglipron, due to elevated liver enzymes and a twice-every day capsule, danuglipron, as a consequence of robust side effects—but CEO Albert Bourla has claimed the company is decided to “Perform and earn” within the obesi